Before chemotherapy , CTCs were detected in 21.5 % of patients ( n = 435 of 2026 ) , with 19.6 % ( n = 136 of 692 ) of node-negative and 22.4 % ( n = 299 of 1334 ) of node-positive patients showing CTCs ( P < .001 ) .